Skip to Main Content

Author Details

Samira M Sadowski
Center for Cancer Research, National Cancer Institute, National Institutes of Health
2012
82
28
PMIDPaper TitleJournal TitlePublished Year
36396453<sup>225</sup>Ac-MACROPATATE: A Novel α-Particle Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors.J Nucl Med2023
36396453<sup>225</sup>Ac-MACROPATATE: A Novel α-Particle Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors.J Nucl Med2023
37568572Models in Pancreatic Neuroendocrine Neoplasms: Current Perspectives and Future Directions.Cancers (Basel)2023
37190198Improvement of Lung NET Management through Standardized Care-A Swiss Nationwide Observational Study.Cancers (Basel)2023
37487000Upregulation of Somatostatin Receptor Type 2 Improves 177Lu-DOTATATE Therapy in Receptor-Deficient Pancreatic Neuroendocrine Tumor Model.Mol Cancer Ther2023
37487000Upregulation of Somatostatin Receptor Type 2 Improves 177Lu-DOTATATE Therapy in Receptor-Deficient Pancreatic Neuroendocrine Tumor Model.Mol Cancer Ther2023
37568572Models in Pancreatic Neuroendocrine Neoplasms: Current Perspectives and Future Directions.Cancers (Basel)2023
37190198Improvement of Lung NET Management through Standardized Care-A Swiss Nationwide Observational Study.Cancers (Basel)2023
36111275Metastatic Grade 3 Neuroendocrine Tumor in Multiple Endocrine Neoplasia Type 1 Expressing Somatostatin Receptors.J Endocr Soc2022
36111275Metastatic Grade 3 Neuroendocrine Tumor in Multiple Endocrine Neoplasia Type 1 Expressing Somatostatin Receptors.J Endocr Soc2022
32971521Multiple Endocrine Neoplasia Type 1 and the Pancreas: Diagnosis and Treatment of Functioning and Non-Functioning Pancreatic and Duodenal Neuroendocrine Neoplasia within the MEN1 Syndrome - An International Consensus Statement.Neuroendocrinology2021
33537001Molecular Signatures and Their Clinical Utility in Pancreatic Neuroendocrine Tumors.Front Endocrinol (Lausanne)2021
33939050Contralateral Suppression Index Does Not Predict Clinical Cure in Patients Undergoing Surgery for Primary Aldosteronism.Ann Surg Oncol2021
32971521Multiple Endocrine Neoplasia Type 1 and the Pancreas: Diagnosis and Treatment of Functioning and Non-Functioning Pancreatic and Duodenal Neuroendocrine Neoplasia within the MEN1 Syndrome - An International Consensus Statement.Neuroendocrinology2021
32943182Pancreatic insufficiency following pancreatectomy: Does underlying tumor syndrome confer a greater risk?Am J Surg2021
33537001Molecular Signatures and Their Clinical Utility in Pancreatic Neuroendocrine Tumors.Front Endocrinol (Lausanne)2021
33939050Contralateral Suppression Index Does Not Predict Clinical Cure in Patients Undergoing Surgery for Primary Aldosteronism.Ann Surg Oncol2021
32943182Pancreatic insufficiency following pancreatectomy: Does underlying tumor syndrome confer a greater risk?Am J Surg2021
32228502The first pancreatic neuroendocrine tumor in Li-Fraumeni syndrome: a case report.BMC Cancer2020
32069215HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: MEN1-related pancreatic NETs: identification of unmet clinical needs and future directives.Endocr Relat Cancer2020
32229700Prognostic factors for the outcome of nonfunctioning pancreatic neuroendocrine tumors in MEN1: a systematic review of literature.Endocr Relat Cancer2020
32228502The first pancreatic neuroendocrine tumor in Li-Fraumeni syndrome: a case report.BMC Cancer2020
32478669Inhibin A as a tumor marker for primary bilateral macronodular adrenal hyperplasia.Endocrinol Diabetes Metab Case Rep2020
32069215HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: MEN1-related pancreatic NETs: identification of unmet clinical needs and future directives.Endocr Relat Cancer2020
32478669Inhibin A as a tumor marker for primary bilateral macronodular adrenal hyperplasia.Endocrinol Diabetes Metab Case Rep2020
32229700Prognostic factors for the outcome of nonfunctioning pancreatic neuroendocrine tumors in MEN1: a systematic review of literature.Endocr Relat Cancer2020
30420090NIFT-P: Are they indolent tumors? Results of a multi-institutional study.Surgery2019
30267071Radioguided Surgery With Gallium 68 Dotatate for Patients With Neuroendocrine Tumors.JAMA Surg2019
30420090NIFT-P: Are they indolent tumors? Results of a multi-institutional study.Surgery2019
30974961High concentration of plasma methoxytyramine: dopamine-producing tumour or Parkinson's disease therapy?Ann Clin Biochem2019
30777201The utility of <sup>68</sup>Gallium-DOTATATE PET/CT in the detection of von Hippel-Lindau disease associated tumors.Eur J Radiol2019
30777201The utility of <sup>68</sup>Gallium-DOTATATE PET/CT in the detection of von Hippel-Lindau disease associated tumors.Eur J Radiol2019
30974961High concentration of plasma methoxytyramine: dopamine-producing tumour or Parkinson's disease therapy?Ann Clin Biochem2019
30267071Radioguided Surgery With Gallium 68 Dotatate for Patients With Neuroendocrine Tumors.JAMA Surg2019
29134377Markers of Systemic Inflammatory Response are Prognostic Factors in Patients with Pancreatic Neuroendocrine Tumors (PNETs): A Prospective Analysis.Ann Surg Oncol2018
28986621Modification of the Surgical Strategy for the Dissection of the Recurrent Laryngeal Nerve Using Continuous Intraoperative Nerve Monitoring.World J Surg2018
3011216368-Gallium DOTATATE scanning in symptomatic patients with negative anatomic imaging but suspected neuroendocrine tumor.Int J Endocr Oncol2018
29923016Incidence and management of postoperative hyperglycemia in patients undergoing insulinoma resection.Endocrine2018
29229628Nationwide multicenter study on the management of pulmonary neuroendocrine (carcinoid) tumors.Endocr Connect2018
29134377Markers of Systemic Inflammatory Response are Prognostic Factors in Patients with Pancreatic Neuroendocrine Tumors (PNETs): A Prospective Analysis.Ann Surg Oncol2018
29659895Identification of Differential Transcriptional Patterns in Primary and Secondary Hyperparathyroidism.J Clin Endocrinol Metab2018
29075773Association of VHL Genotype With Pancreatic Neuroendocrine Tumor Phenotype in Patients With von Hippel-Lindau Disease.JAMA Oncol2018
29155309Prognostic Utility of Total <sup>68</sup>Ga-DOTATATE-Avid Tumor Volume in Patients With Neuroendocrine Tumors.Gastroenterology2018
29785298Impact of near-infrared angiography on the quality of anatomical resection during video-assisted thoracic surgery segmentectomy.J Thorac Dis2018
29405252Randomized clinical trial of intraoperative parathyroid gland angiography with indocyanine green fluorescence predicting parathyroid function after thyroid surgery.Br J Surg2018
29403439Oncocytic Adrenocortical Neoplasm with Concomitant Papillary Thyroid Cancer.Front Endocrinol (Lausanne)2018
28263205Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small ⿤2 cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE Study: Association Francophone de Chirurgie Endocrinienne &amp; Groupe d'Etude des Tumeurs Endocrines.Ann Surg2018
3011216368-Gallium DOTATATE scanning in symptomatic patients with negative anatomic imaging but suspected neuroendocrine tumor.Int J Endocr Oncol2018
29923016Incidence and management of postoperative hyperglycemia in patients undergoing insulinoma resection.Endocrine2018
28263205Long-term Follow-up of MEN1 Patients Who Do Not Have Initial Surgery for Small ⿤2 cm Nonfunctioning Pancreatic Neuroendocrine Tumors, an AFCE and GTE Study: Association Francophone de Chirurgie Endocrinienne &amp; Groupe d'Etude des Tumeurs Endocrines.Ann Surg2018
  • 1 - 50 of 164

Recommended Authors

Randy Yeh
Department of Radiology Memorial Sloan Kettering Cancer Center
Career Start Year 2017
Number of shared co-authors 0
Dipti P Sajed
David Geffen School of Medicine University of California Los Angeles California USA.
Career Start Year 2016
Number of shared co-authors 0
Keith Kwan
Western University
Career Start Year 2009
Number of shared co-authors 0
Pedram Heidari
Massachusetts General Hospital
Career Start Year 2008
Number of shared co-authors 0
Thomas A Hope
University of California san francisco
Career Start Year 2007
Number of shared co-authors 2
Spencer C Behr
University of California san francisco
Career Start Year 2007
Number of shared co-authors 0
Avital Harari
University of California los angeles
Career Start Year 2006
Number of shared co-authors 0
Guido Davidzon
Stanford University
Career Start Year 2005
Number of shared co-authors 0
Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 1
Luc G T Morris
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 1
Jocelyn F Burke
Kirk Kerkorian School of Medicine of University of Nevada
Career Start Year 2002
Number of shared co-authors 0
Michelle D Williams
The University of Texas M. D. Anderson Cancer Center
Career Start Year 2001
Number of shared co-authors 1
Abbas Agaimy
Institute of Pathology, Friedrich-Alexander University Erlangen-Nurnberg (FAU)
Career Start Year 2000
Number of shared co-authors 1
Zhaohui Zhu
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Career Start Year 2000
Number of shared co-authors 0
Jennifer A Chan
Dana-Farber Cancer Institute
Career Start Year 1999
Number of shared co-authors 0
Chuong Bui
Nepean Hospital
Career Start Year 1999
Number of shared co-authors 0
Sung Tae Kim
Busan Paik Hospital, Inje University
Career Start Year 1996
Number of shared co-authors 0
Stephen Y Lai
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 2
Richard T Kloos
Veracyte Inc.
Career Start Year 1995
Number of shared co-authors 0
Udo Rudloff
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 7
Sarah M Dry
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year 1992
Number of shared co-authors 0
Matthew D Ringel
The Ohio State University College of Medicine and Comprehensive Cancer Center
Career Start Year 1991
Number of shared co-authors 1
Mark Gurnell
Wellcome-MRC Institute of Metabolic Science and Addenbrooke's Hospital
Career Start Year 1990
Number of shared co-authors 0
Thomas J Giordano
University of Michigan ann arbor
Career Start Year 1989
Number of shared co-authors 6
Cuong Hoang-Vu
Center for Cancer Research, National Cancer Institute
Career Start Year 1985
Number of shared co-authors 6
Andrew M Lowy
University of California San Diego
Career Start Year 1985
Number of shared co-authors 0
Richard D Schulick
University of Colorado School of Medicine
Career Start Year 1983
Number of shared co-authors 0
Clive S Grant
Inova Health System
Career Start Year 1979
Number of shared co-authors 3
Shereen Ezzat
University of Toronto
Career Start Year 1979
Number of shared co-authors 3
Barbara Jarzab
M. Sklodowska-Curie National Research Institute of Oncology Gliwice Branch
Career Start Year 1976
Number of shared co-authors 1

Collaborators

Electron Kebebew
Stanford University School of Medicine
Co-authored papers 39
Naris Nilubol
Center for Cancer Research
Co-authored papers 30
Dhaval Patel
National Cancer Institute, National Institutes of Health
Co-authored papers 19
Karel Pacak
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Co-authored papers 11
Martha Quezado
National Cancer Institute (NCI), National Institutes of Health (NIH)
Co-authored papers 10
Nicholas J Patronas
Co-authored papers 9
Rachel Aufforth
The University of North Carolina
Co-authored papers 4
Myriem Boufraqech
The University of Texas at Austin
Co-authored papers 4
Stephen J Marx
National Institutes of Digestive Disease and Kidney, National Institutes of Health
Co-authored papers 4
Amit Mehta
Center for Cancer Research, Maryland. Geisel School of Medicine at Dartmouth
Co-authored papers 3
Lisa Zhang
National Institute of Child Health and Development
Co-authored papers 3
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Co-authored papers 3
Ryan J Ellis
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
William Marston Linehan
Co-authored papers 2
Maria J Merino
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Sunita K Agarwal
National Institute of Diabetes and Digestive and Kidney Diseases
Co-authored papers 2
Mark Raffeld
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
William F Simonds
Co-authored papers 2
Ronald M Summers
National Institutes of Health (NIH) Clinical Center
Co-authored papers 2
François Pattou
Co-authored papers 2
Mei He
Sichuan University
Co-authored papers 2
Sudheer Kumar Gara
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Yi Liu-Chittenden
Department of Biochemistry and Howard Hughes Medical Institute, Stanford University
Co-authored papers 1
John A Copland
Mayo Clinic Jacksonville
Co-authored papers 1
Michael T Collins
National Institute of Dental and Craniofacial Research
Co-authored papers 1
Francine B de Abreu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Michael Allg??uer
Institute of Pathology, Heidelberg University Hospital
Co-authored papers 1
Susan R Davis
Co-authored papers 1
Min Shen
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers 1
Sean Davis
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 1
Release 1.2